Market Overview:
The global pediatric cardiac tumor diagnostic market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the pediatric cardiac tumor diagnostic market can be attributed to factors such as rising incidence of childhood cancer, increasing awareness about pediatric heart diseases, and technological advancements in the field of diagnostics. However, the high cost of diagnosis and treatment may restrain the growth of this market during the forecast period. The global pediatric cardiac tumor diagnostic market is segmented on the basis of type into primary cardiac tumors and secondary cardiac tumors. The primary segment is further sub-segmented into benign and malignant tumors. On the basis of application, this market is segmented into hospitals, government health departments, and other segments such as research institutes and laboratories. Geographically, this market is segmented into North America, Latin America, Europe Asia Pacific ,and Middle East & Africa . In 2017 North America accounted for majority share in terms revenue followed by Europe .
Product Definition:
A pediatric cardiac tumor diagnostic is a medical procedure used to determine the presence of a tumor in the heart of a child. This procedure may be used to diagnose tumors that are not typically found in children, such as sarcomas and carcinomas. The importance of pediatric cardiac tumor diagnosis lies in its ability to detect tumors at an early stage, when they are more likely to be treated successfully.
Primary Cardiac Tumors:
Primary cardiac tumors is a group of rare and aggressive heart tumor that began in the cells of the myocardium (cardiac muscle) and their growth factor is called as vascular endothelial growth factor (VEGF).
Secondary Cardiac Tumors:
Secondary cardiac tumors are rare and aggressive heart tumor that develops in the muscle, fat or organs surrounding the heart. These tumors can develop from normal cells; hence they are also known as neoplasm or cancer. The most common sites of secondary cardiac tumor include lungs, liver, kidney and spleen. Secondary cardiac tumors may spread to other organs such as bone, brain or gastrointestinal tract via blood vessels.
Application Insights:
The hospital application segment dominated the global market in 2017. This can be attributed to factors such as availability of advanced healthcare facilities and highly skilled staff, which facilitate rapid diagnosis and treatment of pediatric cardiac tumors. In addition, increasing number of research studies focusing on improving treatment rates for these patients is further driving the growth.
Government health department application segment is expected to witness lucrative growth over the forecast period due to rising awareness programs conducted by various government organizations such as National Cancer Institute (NCI) in collaboration with private institutions across the globe. For instance, NCI-sponsored Global Tumor Initiatives that aim at providing a uniform international standard for cancer data collection and improve access to care through implementation of tumor registries are likely drive this segment over next few years.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, increased government funding for research and development activities, and high disease burden. In addition, favorable reimbursement policies in this region are also expected to boost growth over the forecast period. Asia Pacific is expected to witness lucrative growth during the forecast period owing to increasing healthcare spending by governments as well as private sectors coupled with rising awareness about pediatric cardiac tumors across various countries such as Japan and China. Moreover, an increase in R&D investment by companies is also contributing towards regional growth. For instance; In May 2018; Medtronic plc launched a study called “PEDIATRIC IMPLANTABLE CARDIOSTATIC SUPPORT (ICUS)†that will examine long-term safety data from its ongoing pivotal trial of Icus outside North America for sudden cardiac arrest prevention among children age group 2-17 years old (NCT02690735).
Growth Factors:
- Increasing incidence of pediatric cardiac tumors
- Growing awareness about pediatric cardiac tumors and their diagnosis and treatment options
- Rising demand for better diagnostic tools and techniques for pediatric cardiac tumors
- Technological advancements in the field of pediatric cardiac tumor diagnosis
- Growing number of research studies on pediatric cardiac tumors
Scope Of The Report
Report Attributes
Report Details
Report Title
Pediatric Cardiac Tumor Diagnostic Market Research Report
By Type
Primary Cardiac Tumors, Secondary Cardiac Tumors
By Application
Hospital, Government Health Department, Other
By Companies
Koninklijke Philips, Tomtec Imaging Systems, CardioComm Solutions, Circle Cardiovascular Imaging, Pie Medical Imaging, eMedica, Siemens Healthineers, Shimadzu, Integer Holdings, 3mensio Medical Imaging, HeartSciences
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
186
Number of Tables & Figures
131
Customization Available
Yes, the report can be customized as per your need.
Global Pediatric Cardiac Tumor Diagnostic Market Report Segments:
The global Pediatric Cardiac Tumor Diagnostic market is segmented on the basis of:
Types
Primary Cardiac Tumors, Secondary Cardiac Tumors
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Government Health Department, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Koninklijke Philips
- Tomtec Imaging Systems
- CardioComm Solutions
- Circle Cardiovascular Imaging
- Pie Medical Imaging
- eMedica
- Siemens Healthineers
- Shimadzu
- Integer Holdings
- 3mensio Medical Imaging
- HeartSciences
Highlights of The Pediatric Cardiac Tumor Diagnostic Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Primary Cardiac Tumors
- Secondary Cardiac Tumors
- By Application:
- Hospital
- Government Health Department
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pediatric Cardiac Tumor Diagnostic Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pediatric cardiac tumors are tumors that occur in the heart or other parts of the cardiovascular system in children. These tumors can be benign (noncancerous) or cancerous.
Some of the key players operating in the pediatric cardiac tumor diagnostic market are Koninklijke Philips, Tomtec Imaging Systems, CardioComm Solutions, Circle Cardiovascular Imaging, Pie Medical Imaging, eMedica, Siemens Healthineers, Shimadzu, Integer Holdings, 3mensio Medical Imaging, HeartSciences.
The pediatric cardiac tumor diagnostic market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Pediatric Cardiac Tumor Diagnostic Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Pediatric Cardiac Tumor Diagnostic Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Pediatric Cardiac Tumor Diagnostic Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Pediatric Cardiac Tumor Diagnostic Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Pediatric Cardiac Tumor Diagnostic Market Size & Forecast, 2018-2028
4.5.1 Pediatric Cardiac Tumor Diagnostic Market Size and Y-o-Y Growth
4.5.2 Pediatric Cardiac Tumor Diagnostic Market Absolute $ Opportunity
Chapter 5 Global Pediatric Cardiac Tumor Diagnostic Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Pediatric Cardiac Tumor Diagnostic Market Size Forecast by Type
5.2.1 Primary Cardiac Tumors
5.2.2 Secondary Cardiac Tumors
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Pediatric Cardiac Tumor Diagnostic Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Pediatric Cardiac Tumor Diagnostic Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Government Health Department
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Pediatric Cardiac Tumor Diagnostic Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Pediatric Cardiac Tumor Diagnostic Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Pediatric Cardiac Tumor Diagnostic Analysis and Forecast
9.1 Introduction
9.2 North America Pediatric Cardiac Tumor Diagnostic Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Pediatric Cardiac Tumor Diagnostic Market Size Forecast by Type
9.6.1 Primary Cardiac Tumors
9.6.2 Secondary Cardiac Tumors
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Pediatric Cardiac Tumor Diagnostic Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Government Health Department
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Pediatric Cardiac Tumor Diagnostic Analysis and Forecast
10.1 Introduction
10.2 Europe Pediatric Cardiac Tumor Diagnostic Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Pediatric Cardiac Tumor Diagnostic Market Size Forecast by Type
10.6.1 Primary Cardiac Tumors
10.6.2 Secondary Cardiac Tumors
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Pediatric Cardiac Tumor Diagnostic Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Government Health Department
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Pediatric Cardiac Tumor Diagnostic Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Pediatric Cardiac Tumor Diagnostic Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Pediatric Cardiac Tumor Diagnostic Market Size Forecast by Type
11.6.1 Primary Cardiac Tumors
11.6.2 Secondary Cardiac Tumors
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Pediatric Cardiac Tumor Diagnostic Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Government Health Department
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Pediatric Cardiac Tumor Diagnostic Analysis and Forecast
12.1 Introduction
12.2 Latin America Pediatric Cardiac Tumor Diagnostic Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Pediatric Cardiac Tumor Diagnostic Market Size Forecast by Type
12.6.1 Primary Cardiac Tumors
12.6.2 Secondary Cardiac Tumors
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Pediatric Cardiac Tumor Diagnostic Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Government Health Department
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Pediatric Cardiac Tumor Diagnostic Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Pediatric Cardiac Tumor Diagnostic Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Pediatric Cardiac Tumor Diagnostic Market Size Forecast by Type
13.6.1 Primary Cardiac Tumors
13.6.2 Secondary Cardiac Tumors
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Pediatric Cardiac Tumor Diagnostic Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Government Health Department
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Pediatric Cardiac Tumor Diagnostic Market: Competitive Dashboard
14.2 Global Pediatric Cardiac Tumor Diagnostic Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Koninklijke Philips
14.3.2 Tomtec Imaging Systems
14.3.3 CardioComm Solutions
14.3.4 Circle Cardiovascular Imaging
14.3.5 Pie Medical Imaging
14.3.6 eMedica
14.3.7 Siemens Healthineers
14.3.8 Shimadzu
14.3.9 Integer Holdings
14.3.10 3mensio Medical Imaging
14.3.11 HeartSciences
